The EU Commission approves a merger leading to the creation of one of the largest pharmaceutical companies (Pfizer / Warner-Lambert)

Tretton, Walter; Marshall, Neil

Previous article The Slovak Competition Office approves a merger in the financial sector, subject to the sale of a controlling stake in another bank (Slovenska sporitelna / Priemyselná banka) Next article The Dutch Competition Authority clears a merger in the press sector subject to guaranteeing independence of two regional newspapers (De Telegraaf / De Limburger)

22 May 2000

The EU Commission approves a merger leading to the creation of one of the largest pharmaceutical companies (Pfizer / Warner-Lambert)

KEYWORDS

Reference

EU Commission, Pfizer / Warner-Lambert, Case COMP/M.1878, 22 May 2000

"Merger Control: main developments between 1st May 2000 and 31st August 2000"* Resulting from the merger between Glaxo Wellcome and SmithKline Beecham, the new company, Glaxo SmithKline, will be the world’s biggest pharmaceuticals firm with 7.3% of global sales. The deal raised concerns

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

PDF Version

Authors

Walter Tretton
European External Action Service (Brussels)

Belgium 36 contributions 11530 visits
Neil Marshall
Financial Conduct Authority (London)

United Kingdom 80 contributions 20063 visits

Quotation

Walter Tretton, Neil Marshall, The EU Commission approves a merger leading to the creation of one of the largest pharmaceutical companies (Pfizer / Warner-Lambert), 22 May 2000, e-Competitions May 2000, Art. N° 39149

Visites 234